Fig 1: LAMP3 gene and protein structure. (a) LAMP3 gene representation with the untranslated exonic region (white box) and the six coding exonic regions (black box). Localisation of the proband's variants in red, the recently reported variant in a family with interstitial lung disease in black and the human equivalent of the canine variation in grey. (b) Schematic representation of LAMP3 protein in a lamellar body without its signal peptide (amino acids 1–20). The LAMP (lysosomal-associated membrane protein) domain with disulfide bonds (green) and the transmembrane domain (TM, red) are shown. (c and d) Evolutionary conservation of LAMP3 protein across species (c), and in other members of the LAMP family of proteins (d), with a focus on the LAMP domain (237–376 amino acids) and localisation of the amino acids T268, G288, and E375.
Fig 2: Subcellular localisation of LAMP3. Immunofluorescence staining of HA-tagged LAMP3 wild-type (WT) and T268M, G288R, and E375K mutant proteins in A549 cells. Scale bar correspond to 10 μm. Results are representative of three independent experiments.
Fig 3: Patient. (a) High-resolution computed tomography (CT) scans of the proband carrying bi-allelic LAMP3 variants characterised by ground glass opacities, reticulations, and parenchymal distortion. (b) Sanger electrophoregrams showing the LAMP3 variants from the proband's blood gDNA, lung, and nasal epithelial cells cDNA. The black arrow below the right electrophoregram of the lung cDNA indicates the reading direction of the sequence. (c) Histological analyses of proband and control lung biopsies: haematoxylin and eosin staining (HES) and LAMP3, pro-surfactant protein (SP)-b, SP-B, pro-SP-C, and SP-C immunohistochemistry (IHC). HES revealed septal thickening with hyperplastic alveolar cells and subpleural microcysts, as well as inflammatory interstitial thickening with the presence of lymphocytes. LAMP3 staining revealed a marked lower protein expression for the proband compared to control. Pro-SP-B and SP-B cytoplasmic staining was also slightly reduced in the proband compared to the control. The marked increase of the proSP-C positive cells confirmed type 2 alveolar cell hyperplasia. Scale bar corresponds to 50 μm.
Fig 4: Protein stability prediction and protein expression of WT, T268M, G288R, and E375K LAMP3. (a) Impact of the three variants on protein stability based on human LAMP3 crystal structure of the LAMP domain (PDB: 4AKM). An unfolding Gibbs free energy score (ΔΔG) above 0 is predictive of a destabilising effect (PremPS tool). Oxygen atoms are represented in red; nitrogen atoms are represented in blue; the remaining atoms are in grey. Interactions are represented in dotted lines: van der Waals (green), carbonyl (orange), hydrophobic (blue), and polar (cyan). (b) Protein expression of HA-tagged LAMP3 WT and mutant proteins from lysate, 48 h after transfection in A549 cells. (c) N-glycosylation analysis of HA-tagged LAMP3 WT, T268M, and N266A (as a control for N266 glycosylation loss) performed on protein lysates after digestion with (+) Endo H, PNGase F or without (−) treatment in A549 cells. HA-tagged LAMP3 proteins were fully deglycosylated after Endo H or PNGase F treatments, leading to a shift in electrophoretic mobility to 45–46 kDa. Proteins were detected by immunoblot (IB) using an anti-HA for LAMP3 and anti-GAPDH as a loading control. Protein intensity was quantified by Image J software. Results are representative of three independent experiments. Data are plotted with SD error bars. Unpaired two-tailed Student's t-test was used, p-values < 0.05 were considered statistically significant. ∗∗∗∗p < 0.0001 and non significative (ns) p > 0.05.
Fig 5: Interaction of LAMP3 and surfactant proteins C (SP-C) and B (SP-B). HA-tagged LAMP3 WT or T268M proteins were co-expressed (input) with a empty vector (EV), SP-C FLAG (a) or SP-B (b) and immunoprecipitated (IP) with an anti-HA antibody in A549 cells. Proteins were detected by immunoblot (IB) using an anti-HA antibody for LAMP3, an anti-FLAG antibody for SP-C, an anti-proSP-B antibody for SP-B. GAPDH was used as a loading control. Protein intensity was quantified by Image J software. Results are representative of three independent experiments. Data are plotted with SD error bars. Co-IP levels of SP-C (a) and SP-B (b) with EV, LAMP3 WT and LAMP3 T268M were quantified and normalised with LAMP3 WT. Unpaired two-tailed Student's t-test was used. p-values < 0.05 were considered statistically significant. p-values <0.05 and <0.01 are indicated with ∗ and ∗∗, respectively.
Supplier Page from Sino Biological, Inc. for Human CD208/DC-LAMP Gene ORF cDNA clone expression plasmid, C-HA tag